Granted Patent B2

US 12,496,011 · App. 18/674,684 · Granted Dec 16, 2025

Inventors: Tara L. Crowder (Woodside, CA); Brett M. Wingeier (San Francisco, CA); Martha J. Morrell (Portola Valley, CA); Felice Sun (Palo Alto, CA); Thomas Tcheng (Pleasant Hill, CA)

Assignee: NeuroPace, Inc.

A61B5/4848A61B5/0002A61B5/0031A61B5/24A61B5/377A61B5/0022A61B5/14539A61B5/14553A61B5/4082A61B5/4094

Abstract

Claims (37)

1 . A system for assessing an effectiveness of a drug regimen to which a patient is subjected, the system comprising:

an implantable neurostimulator configured to:

log information as a function of time, the information derived from electrical activity of the patient's brain and comprising one or more of a count of occurrences of epileptiform events, durations of epileptiform events, measures of evoked responses, and power measures of electrographic signals in a specified frequency;

determine a tracked metric based on changes in the information over a time period within which the drug regimen, if effective, would affect the tracked metric; and

deliver electrical stimulation to one or more electrodes in accordance with a plurality of stimulation parameters programmed in the implantable neurostimulator; and

a data management system configured to:

receive the tracked metric from the implantable neurostimulator;

determine the drug regimen is not effective responsive to the tracked metric not satisfying a criterion relative to a corresponding baseline metric; and

output a signal when the criterion is not satisfied, the signal configured to change one or more of the plurality of stimulation parameters programmed in the implantable neurostimulator based on a mechanism of action associated with the drug regimen.

2 . The system of claim 1 , wherein the epileptiform events correspond to a long episode and the information comprises a duration of long episodes that is based on a start time of the long episode and an end time for the long episode.

3 . The system of claim 1 , wherein the implantable neurostimulator is configured to log information without storing a record of the electrographic signals.

4 . The system of claim 1 , wherein electrical activity is sensed from a first location of the patient's brain, and the implantable neurostimulator is configured to periodically deliver an evoked-response electrical stimulation to a second location of the patient's brain, wherein the evoked-response electrical stimulation is configured to produce an evoked response in the electrographic signals.

5 . The system of claim 4 , wherein the first location and the second location are a same location.

6 . The system of claim 4 , wherein the first location and the second location are different locations.

7 . The system of claim 1 , wherein the measures of the evoked responses are an amplitude.

8 . The system of claim 1 , wherein the time period is at least 24 hours.

9 . The system of claim 1 , wherein the data management system is further configured to output an additional signal when the criterion is not satisfied, the additional signal configured to cause a display on a user interface of an external device to indicate an adjustment to one or more parameters of the drug regimen.

10 . The system of claim 9 , wherein the one or more parameters of the drug regimen comprise a drug, a type of the drug, a dosage of the drug, a class of the drug, a method of delivery of the drug, and a timing of delivery of the drug.

11 . The system of claim 1 , further comprising an implantable drug-eluting lead operating in accordance with drug regimen parameters programmed in the implantable neurostimulator, and wherein the data management system is configured to output an additional signal when the criterion is not satisfied, the additional signal configured to change one or more of the drug regimen parameters.

12 . The system of claim 1 , wherein the data management system is configured to generate and display at least one graphical representation related to the information.

13 . The system of claim 12 , wherein the at least one graphical representation comprises a graphical display of the tracked metric as a function of time.

14 . The system of claim 13 , wherein the at least one graphical representation further comprises a graphical display of one or more parameters defining the drug regimen.

15 . A computer-implemented method of assessing an effectiveness of a drug regimen to which a patient with an implanted neurostimulator is subjected, the method comprising:

logging information as a function of time, the information comprising one or more of a count of occurrences of epileptiform events, durations of epileptiform events, measures of evoked responses, and power measures of electrographic signals in a specified frequency;

determining a tracked metric based on changes in the information over a time period within which the drug regimen, if effective, would affect the tracked metric;

determining the drug regimen is not effective responsive to the tracked metric not satisfying a criterion relative to a corresponding baseline metric;

when the criterion is not satisfied, changing one or more of a plurality of stimulation parameters programmed in the implanted neurostimulator based on a mechanism of action associated with the drug regimen; and

delivering electrical stimulation to one or more electrodes in accordance with the changed one or more of a plurality of stimulation parameters programmed in the implantable neurostimulator.

16 . A system for assessing an effectiveness of a drug regimen to which a patient is subjected, the system comprising:

an implantable neurostimulator configured to:

log information as a function of time, the information comprising one or more of a count of occurrences of epileptiform events, durations of epileptiform events, measures of evoked responses, and power measures of electrographic signals in a specified frequency; and

deliver electrical stimulation to one or more electrodes in accordance with a plurality of stimulation parameters programmed in the implantable neurostimulator; and

a data management system configured to:

receive the information from the implantable neurostimulator;

determine a tracked metric based on changes in the information over a time period within which the drug regimen, if effective, would affect the tracked metric;

determine the drug regimen is not effective responsive to the tracked metric not satisfying a criterion relative to a corresponding baseline metric; and

output a signal when the criterion is not satisfied, the signal configured to change one or more of the plurality of stimulation parameters programmed in the implantable neurostimulator based on a mechanism of action associated with the drug regimen.

Assignments (2)

Continuity (5)

References Cited (179)